Fig. 5From: Second-line treatment strategy for urothelial cancer patients who progress or are unfit for cisplatin therapy: a network meta-analysisComparisons: adjusted funnel plots of the first part of the network meta-analysis. A: PFS; B: OS; C: ORR; D: SAEBack to article page